Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vactosertib in Combination With Durvalumab (MEDI4736) in Patients With Gastric Cancer

NCT04893252 is registered in ClinicalTrials.gov with Hark Kyun Kim as lead sponsor.

NCT NCT04893252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04893252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vactosertib in Combination With Durvalumab (MEDI4736) in Patients With Gastric Cancer
Lead sponsor
Hark Kyun Kim
Phase
Phase 2
Overall status
Unknown status
Start date
June 1, 2021
Completion date
December 31, 2023
Enrollment
55 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stomach neoplasm